Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Could blue light-blocking lenses decrease the risk of age-related macular degeneration?

Carolyn Glazer-Hockstein, Joshua L Dunaief

    Retina (Philadelphia, Pa.)
    |January 6, 2006
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ophthalmic Implications of Ehlers-Danlos Syndrome.

    Clinical ophthalmology (Auckland, N.Z.)·2026
    Same author

    Oral Deuterated Docosahexaenoic Acid Protects Against Onset and Progression of RPE Degeneration in a Mouse Model of Chronic Oxidative Stress.

    Investigative ophthalmology & visual science·2026
    Same author

    Temporal and cell-specific changes to cellular iron sequestration and lipid peroxidation in a murine model of neonatal hypoxic-ischemic brain injury.

    Neurobiology of disease·2026
    Same author

    A Remarkable Tale: Increased Retinal Fluorescence Following Application of Permanent Marker Ink to Mouse Tails.

    Investigative ophthalmology & visual science·2026
    Same author

    PLGA nanoparticles restore acidic pH and degradative function to compromised lysosomes with Cy3-labeling providing enhanced tracking to lysosomes.

    American journal of physiology. Cell physiology·2026
    Same author

    Oral Ursodeoxycholic Acid Is Associated With Decreased Rate of AMD.

    Clinical therapeutics·2025
    Same journal

    Persistent placoid maculopathy: long term outcomes and prognostic factors.

    Retina (Philadelphia, Pa.)·2026
    Same journal

    ANTI-VEGF THERAPY SWITCHING RETINAL DISEASES: Characterizing Clinical Manifestations and Common Involved Genes: ERRATUM.

    Retina (Philadelphia, Pa.)·2026
    Same journal

    THE EFFICACY AND SAFETY OF SUBRETINAL BALANCED SALT SOLUTION INJECTION IN DIABETIC MACULAR EDEMA WITH HARD EXUDATES: ERRATUM.

    Retina (Philadelphia, Pa.)·2026
    Same journal

    AMNIOTIC MEMBRANE COVERAGE COMBINED WITH EARLY VITRECTOMY IN THE MANAGEMENT OF PERFORATING GLOBE INJURIES: A NOVEL SURGICAL TECHNIQUE.

    Retina (Philadelphia, Pa.)·2026
    Same journal

    Mid-Phase Hyperfluorescent Plaques as a biomarker of disease activity in Central Serous Chorioretinopathy: Clinical Course and Treatment Response - MICRoN report number Ten.

    Retina (Philadelphia, Pa.)·2026
    Same journal

    Severe retinal non-perfusion is associated with fewer retinal lesions on ultra-wide field fundus photography in proliferative diabetic retinopathy.

    Retina (Philadelphia, Pa.)·2026
    See all related articles

    Blue light-blocking lenses may help age-related macular degeneration patients. Further clinical trials are necessary to confirm if yellow lenses can prevent disease progression.

    Area of Science:

    • Ophthalmology
    • Vision Science
    • Medical Optics

    Background:

    • Epidemiologic and experimental data suggest potential benefits of blue light-blocking lenses for age-related macular degeneration (AMD).
    • AMD is a leading cause of vision loss in older adults, necessitating innovative therapeutic strategies.

    Discussion:

    • The theoretical benefit of blue light-blocking lenses stems from their potential to reduce light-induced retinal damage.
    • Yellow lenses, specifically, are hypothesized to filter harmful wavelengths more effectively.

    Key Insights:

    • Current evidence is largely suggestive, highlighting a need for robust clinical validation.
    • The efficacy of blue light-blocking lenses in AMD management remains to be definitively established through rigorous trials.

    Related Experiment Videos

    Outlook:

    • Clinical trials are essential to ascertain the protective effects of yellow lenses against AMD progression.
    • Future research should focus on quantifying the impact of specific light wavelengths on retinal health in AMD patients.